Evaluation of The Effect of Virtual Reality Glasses

Launched by GOZDE OZ · Jun 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how virtual reality glasses might help reduce anxiety and improve treatment compliance in cancer patients receiving chemotherapy. The researchers want to see if watching special videos through these glasses during treatment can make patients feel less anxious and more likely to stick to their chemotherapy schedule. The study will involve 30 patients, divided into two groups: one group will use the virtual reality glasses while receiving treatment, and the other group will not. Both groups will answer questions about their anxiety and how they cope with their illness before and after the treatment cycles.

To participate in this trial, individuals need to be over 18 years old, able to speak Turkish, and diagnosed with cancer. They should be starting their chemotherapy treatment and able to use virtual reality glasses, without any hearing or vision impairments. This study is not currently recruiting participants, but if you meet the criteria, you could help researchers understand the potential benefits of virtual reality in cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being over 18 years old
• • Knowing Turkish, agreeing to participate in the research
• • Being diagnosed with cancer, regardless of the type of cancer
• • Starting an intravenous chemotherapy treatment regimen after diagnosis
• • Those who receive their treatment in 21-day periods to ensure equality in application frequencies.
• • Able to use virtual reality glasses
• • People without hearing or visual impairment are included
• Exclusion Criteria:
• • Anyone with any visual or hearing impairment
• • The patient does not know the diagnosis of cancer, has been diagnosed with cancer but has not received treatment or has completed the cure.
• • Those with brain tumor or brain metastasis are not included.